Do diabetes patients respond effectively to SARS-CoV-2?

Italian research suggests they do, but hyperglycaemia is still strongly associated with worse outcomes

Patients with type 2 diabetes mount an effective antibody response to the SARS-CoV-2 virus, Italian doctors report.

Coronavirus under antibody attack

Their study also confirms previous research that hyperglycaemia correlates with worse outcomes for patients with COVID-19 pneumonia — with a dose-dependent effect.

And the data shows that diabetes patients are more than twice as likely to die from COVID-19 as those who do not have the condition.

However, the new finding quashes the theory that their immune response might be